09.03.2023 • News

SABIC to Build Catalyst Plants in Saudi Arabia

SABIC has announced it is planning to build three new plants in Saudi Arabia to produce catalysts used in the manufacture of chemicals and polymers.

“SABIC's investment in catalysts will contribute to securing our needs and that of the petrochemical manufacturers in the region,” said acting CEO Abdulrahman Al-Fageeh. He added that despite Saudi leadership in the energy and petrochemical industries, the Kingdom relies to a large extent on catalyst imports, increasing operational risks in the event of any supply chain disruption.

The catalyst plants will form part of a first package of projects for Saudi Arabia’s Shareek program, launched in March 2021 to increase domestic investments of private sector companies through support from government-approved incentives.

SABIC added that it is collaborating with Shareek to “identify the most important enablers and drivers to build the catalyst industry in the Kingdom.”

Last year, Sabic purchased Clariant’s 50% share in the company’s former joint venture Scientific Design, taking full control. Scientific Design is a licensor of high-performance process technologies and a producer of catalysts. The deal allowed SABIC to secure a key catalyst that it uses in glycol manufacturing.

Author: Elaine Burridge, Freelance Journalist

© SABIC (Hadeed)
© SABIC (Hadeed)

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.